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Abstract 
Purpose: To synthesize, and determine the antibacterial activity and binding mode of new pyrazol-
barbituric acid derivatives in a search for new antimicrobial agents. 
Methods: One-pot multi-component reaction of aldehyde derivatives, barbituric acid and 3-methyl-1-
phenyl-1H-pyrazol-5(4H)-one in the presence of NHEt2 to afford Michael adduct was carried out. The 
reaction was carried out in water and afforded new heterocycles in a one-step fashion, with expedient 
work-up and high yield without extraction and purification steps. The synthesized compounds were 
evaluated for antimicrobial activity using agar disc diffusion. Molecular docking approach via MOE-Dock 
program was applied to predict the binding interactions of some of the new pyrazol-barbituric acid 
derivatives against six different target proteins downloaded from Protein Data Bank. 
Results: A series of pyrazole-barbituric acid derivatives were successfully synthesized and 
characterized. The synthesized compounds showed moderate to very good antibacterial activity against 
S. aureus ATCC 29213 and E. faecalis ATCC29212, as well as also antifungal activity against Candida 
albicans ATCC 10400 
Conclusion: A series of pyrazole-barbituric acid derivatives has been synthesized and some of them 
display antimicrobial activities. 
 
Keywords: Pyrazole, Barbituric acid, Pyrazole-barbituric acid derivatives, Antimicrobial activity, 
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Multicomponent reactions (MCRs) are one of the 
most powerful research protocol for generation of 
complex polyfunctionalized molecules using 
convergent one-pot transformations [1-7]. In 
addition, multicomponent reactions in green 
solvent such as water are of considerable 
interest. Nitrogen-containing compounds have 
been known to have a tremendous potential 
application in chemistry. Besides providing great 
biological properties, the nitrogen atoms are able 
to act as donors and find applications in the 
construction of supramolecular blocks. In this 
context, Pyrazole derivatives are of particular 
interest because of their pharmacological profile 
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[8-10] such as cyclooxygenase 2 inhibitors (e.g., 
celecoxib, SC-558, and tepoxalin) (e.g., Fig 1) 
[11,12] and reduction in obesity for example 
cannabinoid-1 inverse agonists (e.g., 
rimonabant) [13]. 
 
In particular, fused pyrazoles with other 
privileged scaffolds possess divergent 
pharmacological activities [14], they are also 
useful in the field of luminophores and 
fluorescence applications [14-20]. 
 
Recently, Barakat et al [21-23], synthesized and 
evaluated some novel zwitterionic adducts 
derived from pyrimidine-2,4,6-trione which 
possess anti-oxidant activity. In this context, we 
have synthesized a  new series of pyrazole-
pyrimidine trione using one pot fashion for the 
construction of new heterocycles. Their anti-





All chemical reagents were purchased from 
Sigma-Aldrich. IR spectra were measured as CsI 
pellets on Perkin-Elmer, FT-IR Spectrometer, 
Spectrum 1000. NMR spectra were recorded on 
a Jeol-400 NMR spectrometer. 1H-NMR (400 
MHz), and 13C-NMR (100 MHz) were run in 
either deuterated chloroform (CDCl3) or 
deuterated dimethylsulphoxide (DMSO-d6). 
Chemical shifts (δ) are referred in terms of ppm 
and J -coupling constants are given in Hz. Mass 
spectra were carried out on a Jeol JMS-600 H 
equipment. Elemental analysis was carried out 
on Perkin-Elmer 2400 Elemental Analyzer; CHN 
mode. All melting points were measured on a 
Gallenkamp melting point apparatus in open 
glass capillaries and are uncorrected. 
 
General method for the synthesis of 4a-o 
(GP1) 
 
A mixture of aldehyde 1 (1.5 mmol), 1,3-
dimethylpyrimidine-2,4,6(1H,3H,5H)-trione 2,  
(1.5 mmol), 3-methyl-1-phenyl-1H-pyrazol-5(4H)-
one (1.5 mmol)  and Et2NH (1.5 mmol, 155 μL) in 
3 mL of degassed H2O was stirred at room 
temperature for 1–5 h. The completion of the 
reaction was monitored by TLC. The solid 
product was filtered, washed with ether (3 × 20 








              Scheme-1: Protocol for the synthesis of 4a-o 
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Table 1: Different S-substituted alkyl groups for 4a-o 
 
# 4 R Yield (%)b 
1 4a Ph 96 
2 4b p-ClPh 93 
3 4c p-CH3Ph 94 
4 4d m-CH3Ph 93 
5 4e p-BrPh 91 
6 4f m-BrPh 88 
7 4g p-NO2Ph 92 
8 4h m-NO2Ph 90 
9 4i p-CH3OPh 89 
10 4j p-FPh 92 
11 4k p-CF3Ph 89 
12 4l 2,4-Cl2Ph 90 
13 4m 2,6-Cl2Ph 87 
14 4n 2-Naphthaldehyde 89 
15 4o Thiophene 85 
aAll reactions were carried out with aldehyde 1(1.5 
mmol), 1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione 
2, (1.5 mmol), 3-methyl-1-phenyl-1H-pyrazol-5(4H)-
one (1.5 mmol) and NHEt2 (1.5 mmol) in water (1.5 
mL) for 1 - 5 h; b yield of isolated product 
 
The different S-substituted alkyl groups for 4a-o 




The initial screening of antimicrobial activity and 
minimum inhibitory concentration (MIC) 
determination for the tested compounds were 
performed by cup plate method and broth dilution 
method respectively with different strains (BSAC, 
2015). Fifteen synthesized compounds were 
screened for their antimicrobial activity against 
six bacterial standard strains; three gram-positive 
(Staphylococcus aureus ATCC 29213, 
Enterococcus faecalis ATCC 29212, and Bacillus 
subtilis ATCC 10400) and three Gram-negative 
(Escherichia coli ATCC 25922, Proteus vulagris 
ATCC 6380, and Pseudomonas aeruginosa 
ATCC 27857) and one unicellular fungi (yeast) 
standard strain) Candida albicans ATCC 2091). 
The tested compounds were dissolved in 
dimethyl sulfoxide (DMSO) to obtain 5120 mg/mL 
stock solution. 
  
Three Gram-positive and three Gram-negative 
bacterial strains and fungi were grown in Cation 
Adjustment Mueller-Hinton (CAMH) broth 
(Merck®, Darmstadt, Germany) while C. albicans 
strain was grown in Sabauraud Dextrose Broth 
(SDB) to mid-log phase. The suspension was 
diluted 1:100 in CAMH broth to obtain 1 x 106 
CFU/mL. This suspension was swabbed on a 
CAMH agar plate (Merck®, Darmstadt, 
Germany) and allowed to dry completely. 
Mueller-Hinton Agar and Sabauraud Dextrose 
Agar were used for bacteria and fungi 
respectively. Four wells (7 mm in diameter) were 
made in agar plate using cork borer. A 1 mL of 
stock solution (5120 mg/mL) was 2-fold diluted in 
1 mL DMSO to obtain 2560 mg/mL. A 100 µL 
(256 µg) of the tested compound was poured in 
the well using calibrated pipette. The plates were 
kept in refrigerator at 4 oC for half an hour to 
allow diffusion of the compound in the agar. 
Then, the plates were incubated at 37 oC for 24 
h. After incubation period, the diameter of the 
inhibition zone was measured and recorded in 
mm by aid of ruler. Ciprofloxacin (10 µg/cup) and 
fluconazole (10 µg/mL) were used as positive 
controls for antibacterial and antifungal activity, 
respectively. The experiment was carried out in 
duplicate and the mean diameter taken [24]. 
 
Determination of minimum inhibitory 
concentration (MIC) 
 
Minimum inhibitory concentration (MIC) was 
determined for the compounds that showed 
antimicrobial activity by cup plate method. Briefly, 
2 mL of CAMH broth (for bacterial strains) and 2 
mL of SAB (for fungal strain) was dispensed into 
7 mL Peju sterile tubes. For each compound, 14 
tubes were used. Tube nos. 13 and 14 were 
used as positive growth control (no test 
compound) and negative control for medium 
sterility (no microorganism), respectively. A 1 mL 
aliquot of the stock solution (5120 mg/mL) was 
10-fold diluted in 9 mL CAMH to obtain 512 
mg/mL. A 2 mL aliquot of the test compounds 
(512 mg/mL) was pipetted into the first tube and 
mixed well. Thereafter, 2 mL was withdrawn from 
the 1st tube and added to the 2nd tube to make 
a two-fold dilution. This procedure was repeated 
down to the 12th tube a concentration of 0.125 
mg/mL was obtained. Two millilitres were 
discarded from the 12th tube. A volume of 2 mL 
of inoculum (1 x 106 CFU/mL) was added to each 
tube except tube no. 14 to give a final strength of 
1 x 106 CFU/mL. Ciprofloxacin and fluconazole 
were used as positive control for antibacterial 
and antifungal assay, respectively. The 
inoculated tubes were incubated at 37 oC for 20 
h. After the incubation period, the results of MIC 
were recorded manually and interpreted 
according to the guidelines of British Society of 




All computations were executed in triplicate and 
statistical analysis was performed with Microsoft 
Excel 2010. The results are expressed as mean 
± SEM (n = 3). Minimum inhibitory concentration 
(MIC) was computed with suitable dilutions (5120 
- 512 μg/well) for each sample and results 
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calculated using EZ-Fit software (Perrella 
Scientific Inc, Amherst, USA)” [24]. 
 
Molecular modeling and docking data 
 
Molecular docking simulation is an efficient tool, 
used to predict binding mode of ligands within 
target proteins binding pockets. In order to 
computationally identify anti-fungal and anti-
bacterial (Gram positive) targets for these newly 
synthesized compounds (4a-4o), six different 
targets proteins were downloaded from the 
Protein Data Bank [25], i.e., dihydrofolate 
reductase (DHFR) (PDB ID 4HOF), secreted 
aspartic protease (PDB ID 3Q70), and N-
myristoyl transferase (PDB ID 1IYL) were chose 
as anti-fungal targets from Candida albicans, 
whereas dihydrofolate reductase (PDB ID 3FYV), 
gyrase B (PDB ID 4URM) and sortase A (PDB ID 
2MLM) were selected from S. aureus as 
antibacterial targets. On the basis of docking 
score and interactions of these compounds 
against all the targets, only two targets, DHFR 
from C. albicans and gyrase B from S. aureus, 
were selected as good docking scores and 
interactions were observed for the synthesized 
compounds using MOE 2013 [25].  
 
Before docking experiment, two dimensional (2D) 
structures of all the compounds were modelled 
on builder implemented in MOE and then their 
three dimensional (3D) conformation were 
generated by MOE. The structure of target 
proteins were prepared, protonated, charged and 
minimized using MOE. Using the default 
parameters of docking in MOE, i.e., TMA 
(Triangle Matcher Algorithm) with London dG 
and GBVI/WSA dG as rescoring functions were 
used to develop 30 binding poses for each 
ligand. All the docking observations along with 
scoring and different conformations of 




The desired zwitterion derivatives 4a-o [24,25] 
bearing different substituents showed excellent 
yield (up to 96 %) as shown in Scheme 1. The 
preparation of 4a-o was ensued via cascade 
Aldol-Michael addition of N,N-dimethyl barbituric 
acid, 3-methyl-1-phenyl-1H-pyrazol-5(4H)-one  
and aldehyde mediated by aquoues NHEt2. 
Notably, a variety of functional groups such as 
hydroxyl, methoxy and chloro were tolerated 
under our new reaction protocol. The chemical 
structures of all the synthesized compounds 







4a was prepared according to (GP1) from 
benzaldehyde yielding orange materials (yield 
96%). m.p: 116 oC; IR (CsI, cm–1): 3449, 3060, 
2988, 1661, 1581, 1501, 1426, 1367;1H-NMR 
(400 MHz, DMSO-d6):  δ 14.48 (s, 1H, OH), 7.33-
7.09 (m, 10H, Ph), 5.52 (s, 1H, benzyl-H), 3.36 
(m, 6H, CH3), 2.88(q, 4H, J = 7.3Hz,  CH2CH3), 
2.19 (s, 3H, CH3),  1.13(t, 6H, J = 7.3Hz, 
CH2CH3); 13C-NMR (100 MHz, DMSO-d6): δ = 
198.0, 174.8, 164.0, 163.6, 163.2, 151.4, 146.9, 
138.0, 128.8, 127.9, 127.5, 126.9, 125.9, 121.9, 
121.8, 91.2, 65.8, 42.1, 12.6, 12.2, 10.7;  Anal. 
for C27H33N5O4; calcd C, 65.97; H, 6.77; N, 
14.25;Found: C, 65.98; H, 6.76; N, 14.24; LC/MS 







4b was prepared according to (GP1) from p-
cholorbenzaldehyde yielding rose materials (yield 
93%). m.p: 162 oC; IR (CsI, cm–1): 3444, 3045, 
2987, 2721, 2495, 1679, 1579, 1502, 1487, 
1370;1H-NMR (400 MHz, CDCl3):  δ 17.62 (s, 1H, 
OH), 8.45 (bs, NH, NHEt2), 7.25-7.13 (m, 10H, 
Ph), 5.46 (s, 1H, benzyl-H), 3.17 (m, 6H, 
CH2CH3), 2.48(q, 4H, J = 7.3Hz,  CH2CH3), 2.16 
(s, 3H, CH3),  1.03(t, 6H, J = 7.3Hz, CH2CH3); 
13C-NMR (100 MHz, CDCl3): δ = 198.2, 174.8, 
164.0, 163.6, 163.2, 151.4, 139.7, 139.1, 131.4, 
128.3, 127.8, 96.8, 91.2, 44.1, 42.1, 34.2, 28.6, 
12.4, 12.3, 11.3; Anal. for C27H32ClN5O4; calcd C, 
61.65; H, 6.13; Cl, 6.74; N, 13.31; Found: C, 







4c was prepared according to (GP1) from p-
toulaldehyde yielding orange materials (yield 
94%). m.p: 147 oC; IR (CsI, cm–1): 3432, 2983, 
2716, 2490, 1683, 1578, 1501, 1362; 1H-NMR 
(400 MHz, DMSO-d6):  δ 14.31 (s, 1H, OH), 9.94 
(bs, NH, NHEt2), 7.35-7.00 (m, 9H, Ph), 5.27 (s, 
1H, benzyl-H), 3.30(t, 6H, J = 7.3Hz, CH2CH3), 
2.42 (s, 3H, CH3),  2.24(s, 3H, CH3), 2.16(s, 3H, 
CH3), 0.86 (t, 6H, J = 7.3Hz, CH2CH3); 13C-NMR 
(100 MHz, CDCl3): δ = 192.5, 163.1, 157.4, 
152.4, 152.2, 147.4, 146.0, 144.6, 139.8, 139.7, 
130.4, 129.4, 128.8, 128.6, 119.9, 119.6, 102.5, 
91.5, 41.2, 31.2, 12.8, 11.1Anal. for C28H35N5O4; 
calcd C, 66.51; H, 6.98; N, 13.85; Found: C, 
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4d was prepared according to (GP1) from m-
toulaldehyde yielding red materials (yield 93%). 
m.p: 98 oC; IR (CsI, cm–1): 3449, 3043, 2987, 
2734, 2509, 1681, 1581, 1501, 1426, 1369; 1H-
NMR (400 MHz, DMSO-d6):  δ 17.40 (s, 1H, OH), 
9.97 (bs, NH, NHEt2), 7.65-7.07 (m, 9H, Ph), 
5.45 (s, 1H, benzyl-H), 2.42(t, 4H, J = 7.3Hz, 
CH2CH3), 2.34 (s, 3H, CH3),  2.24(s, 3H, CH3), 
2.22(s, 3H, CH3), 0.83 (t, 6H, J = 7.3Hz, 
CH2CH3); 13C-NMR (100 MHz, DMSO-d6): δ = 
192.5, 163.1, 157.4, 152.4, 152.2, 147.4, 146.0, 
144.6, 139.8, 139.7, 130.4, 129.4, 128.8, 128.6, 
119.9, 119.6, 102.5, 91.5, 41.4, 21.5, 12.8, 
11.1Anal. for C28H35N5O4; calcd C, 66.51; H, 
6.98; N, 13.85; Found: C, 66.53; H, 6.98; N, 







4e was prepared according to (GP1) from p-
bromobenzaldehyde yielding orange materials 
(yield 91%). m.p: 104 oC; IR (CsI, cm–1): 3451, 
2988, 2737, 2508, 1677, 1581, 1502, 1429, 
1371; 1H-NMR (400 MHz, DMSO-d6):  δ 14.33 (s, 
1H, OH), 9.96 (bs, NH, NHEt2), 7.82 (d, 2H, J = 
7.3Hz, Ph),  7.35-7.07 (m, 7H, Ph), 5.46 (s, 1H, 
benzyl-H), 2.89(t, 4H, J = 7.3Hz, CH2CH3), 3.51 
(s, 6H, CH3),  2.18(s, 3H, CH3), 1.12 (t, 6H, J = 
7.3Hz, CH2CH3); 13C-NMR (100 MHz, DMSO-d6): 
δ = 192.5, 163.1, 157.4, 152.4, 152.2, 147.4, 
146.0, 144.6, 139.8, 139.7, 130.4, 129.4, 128.8, 
128.6, 119.9, 119.6, 102.5, 91.5, 41.2, 31.2, 
12.8, 11.1; Anal. for C27H32BrN5O4; calcd  C, 
56.85; H, 5.65; Br, 14.01; N, 12.28; Found: C, 








4f was prepared according to (GP1) from m-
bromobenzaldehyde yielding orange materials  
(yield 88%). m.p: 163 oC; IR (CsI, cm–1): 3452, 
2989, 2736, 2510, 1678, 1584, 1502, 1429, 
1371; 1H-NMR (400 MHz, DMSO-d6):  δ 14.36 (s, 
1H, OH), 9.95 (bs, NH, NHEt2), 7.89 (d, 1H, J = 
7.3Hz, Ph), 7.31-7.12 (m, 8H, Ph), 5.51 (s, 1H, 
benzyl-H), 2.87(t, 4H, J = 7.3Hz, CH2CH3), 3.50 
(s, 6H, CH3),  2.15(s, 3H, CH3), 1.12 (t, 6H, J = 
7.3Hz, CH2CH3); 13C-NMR (100 MHz, DMSO-d6): 
δ = 192.5, 163.1, 157.3, 152.4, 152.1, 148.3, 
147.4, 146.0, 140.4, 139.7, 130.0, 129.4, 128.8, 
128.6, 123.4, 119.9, 119.6, 102.5, 91.5, 41.2, 
31.2, 12.9, 11.1; Anal. for C27H32BrN5O4; calcd  
C, 56.85; H, 5.65; Br, 14.01; N, 12.28; Found: C, 








4g was prepared according to (GP1) from p-
nitrobenzaldehyde yielding paige materials  (yield 
92%). m.p: 195 oC; IR (CsI, cm–1): 3453, 3062, 
2989, 2507, 1678, 1585, 1513, 1454, 1346; 1H-
NMR (400 MHz, DMSO-d6):  δ 17.53 (s, 1H, OH), 
10.15 (bs, NH, NHEt2), 8.03 (d, 2H, J = 7.3Hz, 
Ph), 7.57 (d, 2H, J = 7.3Hz, Ph), 7.57-7.25(m, 
5H, Ph), 5.57 (s, 1H, benzyl-H), 3.33 (s, 6H, 
CH3),  3.32(t, 4H, J = 7.3Hz, CH2CH3), 2.08(s, 
3H, CH3), 0.96(t, 6H, J = 7.3Hz, CH2CH3);13C-
NMR (100 MHz, DMSO-d6): δ 192.7, 163.1, 
157.3, 152.4, 152.1, 148.3, 147.4, 146.0, 140.4, 
139.7, 130.0, 129.4, 129.0, 128.6, 123.4, 119.9, 
119.6, 102.5, 91.5, 42.0, 28.5, 12.9, 11.1; Anal. 
for C27H32N6O6; calcd C, 60.44; H, 6.01; N, 
15.66; Found: C, 60.44; H, 6.02; N, 15.67; 







4h was prepared according to (GP1) from m-
nitrobenzaldehyde yielding orange materials  
(yield 90%). m.p: 116 oC; IR (CsI, cm–1): 3451, 
2990, 2508, 1677, 1583, 1526, 1348; 1H-NMR 
(400 MHz, DMSO-d6):  δ 14.10 (s, 1H, OH), 
10.11(bs, NH, NHEt2), 7.60 (d, 1H, J = 7.3Hz, 
Ph), 7.60-7.15 (m, 8H, Ph), 5.59 (s, 1H, benzyl-
H), 3.33 (s, 6H, CH3),  2.50(t, 4H, J = 7.3Hz, 
CH2CH3), 2.23(s, 3H, CH3), 1.00 (t, 6H, J = 
7.3Hz, CH2CH3);13C-NMR (100 MHz, DMSO-d6): 
δ 192.5, 163.1, 156.3, 152.4, 152.1, 148.3, 
146.9, 138.9, 129.4, 128.8, 128.6, 125.9, 122.5, 
122.3, 122.1,  121.1, 102.5, 91.5, 42.0, 34.3, 
28.7, 12.7, 11.3; Anal. for C27H32N6O6; calcd C, 
60.44; H, 6.01; N, 15.66; Found: C, 60.45; H, 
6.02; N, 15.65; LC/MS (ESI): 537[M]+. 
 
Barakat et al 







4i was prepared according to (GP1) from 
anisaldehyde yielding orange materials  (yield 
89%). m.p: 105 oC; IR (CsI, cm–1): 3455, 2998, 
273, 2502, 1681, 1584, 1556, 1499, 1430, 1361, 
1268;1H-NMR (400 MHz, DMSO-d6):  δ 14.50(s, 
1H, OH), 8.68 (bs, NH, NHEt2), 7.76 (d, 2H, J = 
7.3Hz, Ph), 7.41 (d, 2H, J = 7.3Hz, Ph), 7.19-
7.08 (m, 5H, Ph), 5.51 (s, 1H, benzyl-H), 3.85 (s, 
6H, CH3),  2.28(s, 3H, CH3), 3.44(t, 4H, J = 
7.3Hz, CH2CH3), 2.28(s, 3H, CH3), 1.06 (t, 6H, J 
= 7.3Hz, CH2CH3); 13C-NMR (100 MHz, DMSO-
d6): δ = 192.5, 163.5, 161.8, 157.4, 151.7, 147.9, 
146.1, 138.4, 136.8, 136.8, 128.8, 128.7, 126.2, 
120.2, 118.3, 114.3, 113.4, 104.6, 91.5, 55.6, 
41.9, 31.2, 18.5, 15.1, 13.1, 11.8; Anal. for 
C28H35N5O5; calcd C, 64.47; H, 6.76; N, 13.43; 








4j was prepared according to the general 
procedure (GP1) from p-flurobenzaldehyde 
yielding orange materials  (yield 92%). m.p: 108 
oC; IR (CsI, cm–1): 3452, 3064, 2991, 2739, 
2511, 16800, 1582, 1503, 1455, 1370; 1H-NMR 
(400 MHz, DMSO-d6):  δ 14.40(s, 1H, OH), 9.95 
(bs, NH, NHEt2), 7.86 (d, 2H, J = 7.3Hz, Ph), 
7.36 (d, 2H, J = 7.3Hz, Ph), 7.36-6.96 (m, 5H, 
Ph), 5.49 (s, 1H, benzyl-H), 3.50 (s, 6H, CH3),  
2.87(t, 4H, J = 7.3Hz, CH2CH3), 2.17(s, 3H, CH3), 
1.12 (t, 6H, J = 7.3Hz, CH2CH3); 13C-NMR (100 
MHz, DMSO-d6): δ = 191.8, 163.5, 161.8, 157.3, 
152.4, 152.2, 147.4, 146.0, 140.1, 139.7, 128.7, 
128.6, 128.5, 123.7, 119.9, 119.5, 102.9, 91.7, 
41.9, 31.5, 28.5, 12.8, 11.11; Anal. for 
C27H32FN5O4; calcd C, 63.64; H, 6.33; F, 3.73; N, 
13.74; Found: C, 63.65; H, 6.35; F, 3.70; N, 







4k was prepared according to (GP1) from p-
trifluromethylbenzaldehyde yielding orange 
materials  (yield 89%). m.p: 171 oC; IR (CsI, cm–
1): 3452, 3063, 2992, 2510, 1664, 1582, 1502, 
1430, 1326; 1H-NMR (400 MHz, DMSO-d6):  δ 
17.40 (s, 1H, OH), 10.09(bs, NH, NHEt2), 7.54 
(d, 1H, J = 7.3Hz, Ph), 7.42-7.25 (m, 8H, Ph), 
5.57 (s, 1H, benzyl-H), 3.31 (s, 6H, CH3),  2.89(t, 
4H, J = 7.3Hz, CH2CH3), 2.29(s, 3H, CH3), 0.88 
(t, 6H, J = 7.3Hz, CH2CH3);13C-NMR (100 MHz, 
DMSO-d6): δ 192.5, 163.1, 156.3, 152.4, 152.1, 
148.3, 146.9, 138.7, 128.8, 128.7, 128.0, 127.3, 
125.8, 124.8, 122.1, 119.5, 102.5, 91.5, 41.5, 
34.3, 28.2, 12.6, 11.0; Anal. for C28H32F3N5O4; 
calcd C, 60.10; H, 5.76; F, 10.19; N, 12.52; 
Found: C, 60.11; H, 5.75; F, 10.21; N, 12.54; 







4l was prepared according to (GP1) from 2,4-
dicholrobenzaldehyde yielding orange materials  
(yield 90%). m.p: 109 oC; IR (CsI, cm–1): 3450, 
3064, 2989, 2735, 2509, 1680, 1583, 1501, 
1456, 1376; 1H-NMR (400 MHz, DMSO-d6):  δ 
14.30 (s, 1H, OH), 10.40(bs, NH, NHEt2), 7.53 
(d, 1H, J = 7.3Hz, Ph), 7.27-7.09 (m, 7H, Ph), 
5.48 (s, 1H, benzyl-H), 3.31 (s, 3H, CH3),  3.18 
(s, 3H, CH3),  2.36(t, 4H, J = 7.3Hz, CH2CH3), 
2.27(s, 3H, CH3), 0.89 (t, 6H, J = 7.3Hz, 
CH2CH3);13C-NMR (100 MHz, DMSO-d6): δ 
188.7, 163.1, 156.9, 146.9, 138.5, 133.7, 132.2, 
131.7, 129.1, 129.0, 128.9, 128.8, 126.6, 125.8, 
122.2, 119.1, 102.7, 91.4, 41.2, 32.4, 28.22, 
12.7, 11.0, 10.9;  Anal. for C27H31Cl2N5O4; calcd 
C, 57.86; H, 5.57; Cl, 12.65; N, 12.50; Found: C, 








4m was prepared according to (GP1) from 2,6-
dicholrobenzaldehyde yielding yellow materials  
(yield 97%). m.p: 88 oC; IR (CsI, cm–1): 3449, 
2988, 2787, 2507, 1677, 1582, 1499, 1431, 
1370; 1H-NMR (400 MHz, DMSO-d6):  δ 14.30 (s, 
1H, OH), 10.40(bs, NH, NHEt2), 7.53 (d, 1H, J = 
7.3Hz, Ph), 7.36-7.21 (m, 7H, Ph), 5.77 (s, 1H, 
benzyl-H), 3.07 (s, 6H, CH3),  2.87(t, 4H, J = 
7.3Hz, CH2CH3), 1.96(s, 3H, CH3), 1.13 (t, 6H, J 
= 7.3Hz, CH2CH3);13C-NMR (100 MHz, DMSO-
d6): δ 188.7, 163.1, 156.9, 146.9, 138.5, 133.7, 
132.2, 131.7, 129.1, 129.0, 128.9, 128.8, 126.6, 
125.8, 122.2, 119.1, 102.7, 91.4, 41.2, 32.4, 
28.22, 12.7, 11.0, 10.9;  Anal. for C27H31Cl2N5O4; 
calcd C, 57.86; H, 5.57; Cl, 12.65; N, 12.50; 
Found: C, 57.87; H, 5.58; Cl, 12.63; N, 12.52; 
LC/MS (ESI): 561[M]+. 
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4n was prepared according to (GP1) from 
naphthaldehyde yielding orange materials  (yield 
89%). m.p: 94 oC; IR (CsI, cm–1): 3448, 3054, 
2988, 2735, 2507, 1681, 1851, 1502, 1427, 
1368; 1H-NMR (400 MHz, DMSO-d6):  δ 14.38(s, 
1H, OH), 10.15 (bs, NH, NHEt2), 7.64-7.23 (m, 
12H, Ph), 5.69 (s, 1H, benzyl-H), 3.23 (s, 6H, 
CH3),  2.22(t, 4H, J = 7.3Hz, CH2CH3), 1.97(s, 
3H, CH3), 0.58 (t, 6H, J = 7.3Hz, CH2CH3); 13C-
NMR (100 MHz, DMSO-d6): δ = 192.5, 164.6, 
156.5, 152.7, 147.1, 129.6, 129.2, 128.8, 128.2, 
127.4, 125.7, 121.9102.9, 91.7, 41.2, 34.2, 28.3, 
14.4, 12.8, 10.8, 10.10.6; Anal. for C31H35N5O4; 
calcd C, 68.74; H, 6.51; N, 12.93; Found: C, 







4o was prepared according to (GP1) from 
thiophenldehyde yielding red materials  (yield 
85%). m.p: 103 oC; IR (CsI, cm–1): 3451, 3079, 
2988, 2740, 2504, 1682, 1582, 1500, 1413, 
1336, 1304, 1210; 1H-NMR (400 MHz, DMSO-
d6): δ 14.30 (s, 1H, OH), 8.70 (bs, NH, NHEt2), 
7.98(d, 2H, J = 7.3Hz,  thiophene), 7.59 (d, 1H, J 
= 7.3Hz,  thiophene),7.98-7.07 (m, 6H, Ph), 5.67 
(s, 1H, benzyl-H), 3.16 (s, 6H, CH3),  2.33(t, 4H, 
J = 7.3Hz, CH2CH3), 2.20(s, 3H, CH3), 0.77 (t, 
6H, J = 7.3Hz, CH2CH3); 13C-NMR (100 MHz, 
DMSO-d6): δ = 192.8, 162.3, 156.4, 150.2, 146.6, 
140.9, 138.7, 138.4, 138.3, 136.8, 136.5, 128.9, 
128.8, 124.9, 121.9, 119.1, 104.1, 91.4, 41.5, 
30.6, 28.3, 13.1, 12.4, 10.8; Anal. for 
C25H31N5O4S; calcd C, 60.34; H, 6.28; N, 14.07; 
S, 6.44.; Found: C, 60.34; H, 6.27; N, 14.10; S, 
6.45; LC/MS (ESI): 498 [M]+.  
 
The desired compounds 4a-o were synthesized 
in one step fashion in high yield. The chemical 
structure was assigned via different 
spectroscopic tools including NMR, IR, MS and 
CHN elemental analysis. 
 
A possible mechanism for the tandem Aldol- 
Michael reaction is shown in scheme 2. In the 
first step of the reaction, olefin is produced by 
Aldol condensation between aryl aldehyde 1 and 
either 2 or 3 promoted by diethyl amine (DEA). 
The Michael addition occurred in the second step 
via addition of enolate into olefin to afford the 




          Scheme 2: Probable mode of tandem Aldol- Michael reaction 
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Results of the biological activity are shown in 
Table 2 and are expressed in mm inhibition. All 
the compounds exhibited very good activity 
against Gram-positive bacteria and fungi. The 
most promising compound against C. albicans 
was 4j. Compounds 4a-o had no activity against 
Gram-negative bacteria including Escherichia 
coli ATCC 25922, Proteus vulagris ATCC 6380, 




Visual inspection of the binding mode of these 
newly synthesized compounds were carried out 
to determine the promising anti-fungal and anti-
bacterial (gram-positive) agents. 
 
As shown for the in vitro observations, the 
docking results confirmed the anti-fungal and 
gram positive anti-bacterial activity of these 
compounds, especially 4j and 4c, revealed good 
interactions against the two target proteins (Fig. 
2). Although, compounds 4h, 4i, 4l, 4n and 4o 
have some sort of activity but they did not show 
good interactions against the target proteins 
(4HOF and 4URM) like compound 4j and 4c. 
Moreover, molecular docking of 4j against 4HOF 
showed that three hydrogen bonds and one 
arene-cation interaction with the active site 
residues Thr58, Lys57 and Arg56 respectively of 
protein (Figure 2a), Alternatively, docking 
simulation with gyrase B (PDB ID: 4URM) 
revealed that the carbonyl oxygen of compound 
4j was involved in hydrogen bonding with active 
site residues Ile86 and Gly85 (Fig. 2b). In case of 
compound 4c, good interactions were observed 
with the active site residues of target protein 
4HOF (Figure 2c) and 4URM (Figure 2d). The 
orientation of the compound 4j and 4c in the 
active site of the target proteins are represented 
in Figure 3. Overall our docking results showed 
that all the synthesized compounds, particularly 
compounds 4j and 4c revealed significant 
hydrogen bonds and hydrophobic interactions 
with the important active site residues of 4HOF 
and 4URM and are the promising anti-fungal and 




In conclusion, a new series of Michael adducts 
combined pyrazol-barbituric acid pharmacophore 
are synthesized and characterized. The 
synthesized products were examined against 
antimicrobial activity and also the molecular 
docking was investigated. 
 







Gram positive bacteria Yeast 
























1 4a 12 32 12 16 11 32 14 32 
2 4b 12 32 14 32 11 32 14 32 
3 4c 13 32 13 32 12 32 18 8 
4 4d 14 32 15 16 14 16 14 32 
5 4e 15 32 12 64 11 64 14 32 
6 4f 14 32 13 32 13 32 15 16 
7 4g 14 32 14 32 13 32 15 16 
8 4h 15 32 15 32 14 32 12 128 
9 4i 15 32 19 32 15 16 13 64 
10 4j 14 32 14 16 15 32 17 8 
11 4k 12 32 12 32 11 32 16 16 
12 4l 10 >128 Nil >128 13 32 10 >128 
13 4m 12 32 12 32 14 16 16 16 
14 4n 13 64 11 64 12 64 14 32 
15 4o 13 64 11 64 14 16 15 16 
Standard Ciprofloxacin 27 ≤0. 25 24 ≤0.25 25 ≤0.25 ND ND 
Fluconazole ND ND ND ND ND ND 28 0.5 
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Figure 2: (a) Molecular docking conformation of compound 4j in the active site of 4HOF; (b) Molecular docking 
conformation of compound 4j in the active site of 4URM; (c) Molecular docking conformation of compound 4c in 




Figure 3: Binding orientation of compound 4j and 4c in the active sites of 4HOF and 4URM 
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